Mammoth Biosciences develops low-cost DNA tests that have the potential to make medical diagnostics more accessible and affordable. DNA tests are routinely performed to detect infection and to diagnose disease. Many of these tests, however, are performed using expensive, centralized instruments. The benefits of Mammoth’s platform are to enable physicians to more quickly and comprehensively diagnose and treat disease, even in recourse constrained settings. Current federal and state regulations require prior approval by the FDA and the supervision of a physician for use. Consequently, the risk of inappropriate use, erroneous results, or of patients misunderstanding the results of Mammoth’s tests is low.